{"name":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","slug":"merck-healthcare-kgaa-darmstadt-germany-an-affiliate-of-merck-kgaa-darmstadt-ger","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"Evobruitnib","genericName":"Evobruitnib","slug":"evobruitnib","indication":"Other","status":"phase_1"},{"name":"Coriogonadotropin alfa","genericName":"Coriogonadotropin alfa","slug":"coriogonadotropin-alfa","indication":"Luteal phase support in assisted reproductive technology (ART) / in vitro fertilization (IVF)","status":"phase_3"},{"name":"Palcebo","genericName":"Palcebo","slug":"palcebo","indication":"Other","status":"phase_3"},{"name":"Reference Eutirox®","genericName":"Reference Eutirox®","slug":"reference-eutirox","indication":"Other","status":"phase_1"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Cladribine Low Dose","genericName":"Cladribine Low Dose","slug":"cladribine-low-dose","indication":"Multiple sclerosis (relapsing-remitting and progressive forms)","status":"phase_3"},{"name":"Mavenclad®","genericName":"Mavenclad®","slug":"mavenclad","indication":"Relapsing-remitting multiple sclerosis (RRMS)","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Cladribine High Dose","genericName":"Cladribine High Dose","slug":"cladribine-high-dose","indication":"Hairy cell leukemia","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"Enpatoran low dose","genericName":"Enpatoran low dose","slug":"enpatoran-low-dose","indication":"Chronic kidney disease (CKD) with or without diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Cladribine High Dose","genericName":"Cladribine High Dose","slug":"cladribine-high-dose","phase":"phase_3","mechanism":"Cladribine is a purine nucleoside analog that depletes lymphocytes by being incorporated into DNA and causing strand breaks, leading to selective destruction of immune cells.","indications":["Hairy cell leukemia","Chronic lymphocytic leukemia","Multiple sclerosis (relapsing-remitting)"],"catalyst":""},{"name":"Evobruitnib","genericName":"Evobruitnib","slug":"evobruitnib","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cladribine Low Dose","genericName":"Cladribine Low Dose","slug":"cladribine-low-dose","phase":"phase_3","mechanism":"Cladribine is a purine nucleoside analog that depletes lymphocytes by inhibiting ribonucleotide reductase and inducing apoptosis in dividing cells.","indications":["Multiple sclerosis (relapsing-remitting and progressive forms)","Lymphoproliferative disorders"],"catalyst":""},{"name":"Coriogonadotropin alfa","genericName":"Coriogonadotropin alfa","slug":"coriogonadotropin-alfa","phase":"phase_3","mechanism":"Coriogonadotropin alfa is a recombinant human chorionic gonadotropin (hCG) analog that stimulates the corpus luteum to produce progesterone for luteal phase support in assisted reproductive technology.","indications":["Luteal phase support in assisted reproductive technology (ART) / in vitro fertilization (IVF)"],"catalyst":""},{"name":"Enpatoran low dose","genericName":"Enpatoran low dose","slug":"enpatoran-low-dose","phase":"phase_2","mechanism":"Enpatoran low dose is a small molecule that acts as a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Chronic kidney disease (CKD) with or without diabetes","Heart failure"],"catalyst":""},{"name":"Mavenclad®","genericName":"Mavenclad®","slug":"mavenclad","phase":"marketed","mechanism":"Mavenclad (cladribine) is a purine nucleoside analog that depletes lymphocytes by interfering with DNA synthesis and repair in dividing cells.","indications":["Relapsing-remitting multiple sclerosis (RRMS)","Active secondary progressive multiple sclerosis (SPMS)"],"catalyst":""},{"name":"Palcebo","genericName":"Palcebo","slug":"palcebo","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Reference Eutirox®","genericName":"Reference Eutirox®","slug":"reference-eutirox","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTzViUkstSHc1dHA5M29GWjlWM0JSWGFnOFl6eDVxXzNwWklBM2ZJU0l3Q0kzX3hod1dILUVzaXFMSjBVajM5aXZDNFpaQ2hFOVMya1loek5PbnN2MExwMnZ4dEE3RFMwU1R1M0U0LW9sZTBqd0s2by16Uk1UTXZvUm5hMk9XaGNIcWk5RklTNFBiTWdwOHJMeFNJTExDdHRneXR6WDBKaWh1UDI3dUZycE52MDgwLUFXWVc0U3E0dXZFWVhKUnlWUm1sLTRYOEpMU0E?oc=5","date":"2025-11-20","type":"deal","source":"Reuters","summary":"Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters","headline":"Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPRlB0UHhJVWFYeTlJTTFYbkM4TTk4T0NBX1FtUnpabjZvUUpjS2daZTBJMTIwYW56bnROU2FOTnpIMjRkRFFkZTNSMEJ6cVlrMGZNR1NlSzIxZFdWdjBEaU5jNUc4cF9ST3V1anVuNEYxLWtfSU1CX2djUW1rczByZWFNYmphTVdZM0ZrcVpqVGhMbkp1bmU1Q29ZRVMzMGp1QjhheUxWbFJQdDk3Y3RLMmpib1BLYzls?oc=5","date":"2025-11-12","type":"earnings","source":"Reuters","summary":"Merck KGaA's Q3 profit rises, beats market view - Reuters","headline":"Merck KGaA's Q3 profit rises, beats market view","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNN2NkeUttc2FXUDI5ZkNlWG5YX1lDOUxXZy1IdWNGYkFweWt1dnMxWnF5UFhUMHdFYU95RFRIeURZRTVoZXg2SjNBN3VvVXFzQjJVN0IxeTVEMldvTHpfbXZCcVBqUjRMNDJTNHBpLUc1bEFkR0ZwRkRBeWg5bXRNREVkUFQ3VFJreVVsbDJIczVZbHV0M01EcUtjRUU3QzJCc3FTeG1PVUtCeEhtLVItckViUUZ4bWZKd2czM0pTUHVwOG9yQUE?oc=5","date":"2025-10-16","type":"deal","source":"Reuters","summary":"Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares - Reuters","headline":"Germany's Merck eyes life science deals, but muted 2026 outlook knocks shares","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPMjNXNWhxMlBvTmF3eWs5WEJzS1JMNms4QlhCb3l1aDdjZEh3NGxESEhWV0xaaWIxbWFVWHhRTWdjWGJPZ3pvYUFKcU5Cd3NyRzU3MGpzR2NjR0t2WTFZR1lqbDg1eW1DLUFlZDQyUk1UMUl0SmE0SUU1RDhrbC01SGdnNkVFYjVCaE80WGMxdXlERE1ERWVLRTBjWHd1emd5TWhjQ2JQdmtNVm9FRFpfQzh2N2pieG4wTmxaZkxCejdtZmJMU2VxbkdhOU91OGE5aC1RSjNnajg?oc=5","date":"2025-09-02","type":"pipeline","source":"Contract Pharma","summary":"Merck KGaA, Darmstadt, Germany Names New Global Head of R&D and CMO for Healthcare Business Sector - Contract Pharma","headline":"Merck KGaA, Darmstadt, Germany Names New Global Head of R&D and CMO for Healthcare Business Sector","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNaWt1OWZZS1VmUUVJRWt3djlzcnAxcV94eGlGWENYbWRrMUp4amtnUUkxUHBqWmYyQ0pZMHo2RlVFZl9tVUdoSnRKY2NhTnhDM0xIXzJac1JzVUloOEZ5TDZrVVA1SzdVbmlNZkdZbGhXcFNYVGRiVk1fczBiUEQ0VnJ3RGFJblVZ?oc=5","date":"2025-08-15","type":"pipeline","source":"Pharma Voice","summary":"Merck KGaA ventures into new territory in the US - Pharma Voice","headline":"Merck KGaA ventures into new territory in the US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPVDg4QkVpM2tiZkhPVXVGUHk2UWc0TENnUjRYY1R0Q3JidGVfSUwzVTdJQ2dQUm9GQWNvbjd4YmttWDFTWXJ6MnBQZnFTd2s3Z0Q5RndJWGNQSzBnaHRmOUZ3Wk5SNGx5cHA4Q2I0TXYyV2huODQ4d09oRVVUR2VsS0xJMDdoRFVLOHNmZFBmMjZidk0wY29iWTE0bVFWNzVJcUcyWGtLRElLQzNkZXA1MWVrdDNYWWxS?oc=5","date":"2025-07-01","type":"deal","source":"Contract Pharma","summary":"Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M - Contract Pharma","headline":"Merck KGaA, Darmstadt, Germany Acquires SpringWorks Therapeutics for $3.4M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNUWpTSjlla05LTm90Tkg4c1hwYzVCZWczamdvTVAwV2xUTl9MdUZVQWpqdFV6Z1VPdHZWRVhsS0k2UWRHclBreFNzdzctSkRSeE1zNHRZV2dGc21JWjVjb09rc29YNUZPWDhLRjJZSE9BZUNRSFJNRjc4ZllEVkFlcEdCaHdzTWxmbk9DbWpISVlSTHhLcXE2WWVxVDdpRGFtdFBuWlMwN09LTTN5UEpjcVduVFY4VlVUZlRRTg?oc=5","date":"2025-05-15","type":"pipeline","source":"Fierce Pharma","summary":"Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast - Fierce Pharma","headline":"Merck KGaA cites Trump tariffs, funding cuts as it scales back 2025 contracting forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOU2h5ZVp2bTdTWUFaMnYyN3NLNVVTVWt4QXplYjdZODZxY05mYjBmZ3hxTGFPTkNscG04X1A1ODlxaTYwUzFkMVNxN1RqZDhGWkFTUUpYMnlMRGFNMVA0Sk9BcDZTbjdRdEFqMS1rV3VBUXdDZlhMQTUwVXdydGV2Vk1fSG1lTkJZdWlhTU5LZw?oc=5","date":"2025-04-28","type":"deal","source":"Contract Pharma","summary":"Merck KGaA Agrees to Acquire SpringWorks - Contract Pharma","headline":"Merck KGaA Agrees to Acquire SpringWorks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFBVdHk0RHV3ekotUFFfOVE3djhBcGdxWGN2MlkwNkVqQ0MwMU5iTUVFX1RtZVF0S0c3Wk9QdVNlc1ExS3VES2JSUmctOFBpRTJvUTl3d0c5aUUyLWxNZEVZcVBDSTBBNklwcWNTQTJXeU5NY2J6V0FTeg?oc=5","date":"2025-02-19","type":"pipeline","source":"Pharmaceutical Technology","summary":"New CEOs to join Merck KGaA’s executive board - Pharmaceutical Technology","headline":"New CEOs to join Merck KGaA’s executive board","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNNmFCVlVxOWhzSkV1a2xFamVES0FQNEozOEUwRTlGR3dwczVFc2F3eDJQZFNBVldmY0huUk42TEVHQjdmQzVsR2ZQLV9abkVBNUcxU0VLVFJFeHpPcEVLMXh6ZzRhUDNiaTVkVGZwNWptYlhVclVkMC16bll4cDdsRWZXeHRmVmpSa1p5M2NqTm9hbGhxZm9wczZDUFd1OFFIZklB?oc=5","date":"2024-08-07","type":"pipeline","source":"Fierce Pharma","summary":"After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound - Fierce Pharma","headline":"After sharp declines, Merck KGaA and analysts share optimism about potential CDMO rebound","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTFBTQk84b3l4c2VJVjQtNFhRd3BoS2VtZ0ZjVEZ0M3BFR3F1Y2FHS3VmbzRfNC0zQk1vWlREZGpDc1BSdEhyNUpsUzJuOGptMTJzaEJSdUR2Sk5jNms?oc=5","date":"2020-11-17","type":"pipeline","source":"EurekAlert!","summary":"Merck KGaA, Darmstadt, Germany to deploy Insilico Medicine's Chemistry42 AI platform - EurekAlert!","headline":"Merck KGaA, Darmstadt, Germany to deploy Insilico Medicine's Chemistry42 AI platform - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxObGo2WFU2UUhWR1RGT0xnME43YXgyR3h4VDdvcHZqcWVjWnVmNUlsNkNTVEZjU0w1dWk1TlBsWGtwVDV6ZS1DRG5xcTdUV0dTeFkwRDFiSko5UW5KeWpGN1FDNzEwNG9QakN5UkJnSFUwRHJma0lRVHRxV1cxZGVjSzhFcmxVRGlOS2R3b1pBazNiLU5YVW02cjIxMDR1TWJtTkNCYkJDeFk3c3dQM3J0TFNFeEM4Q2RuQ1RmSUtJanpENE5zSjNtbU5HU0Z4WDFvejAtcVVGTXRBMkxGNk1rb2xvYzVZVzV6eDUxT3Blaw?oc=5","date":"2020-10-15","type":"pipeline","source":"prnewswire.com","summary":"Merck KGaA, Darmstadt, Germany, Announces Retirement of Luciano Rossetti, Global Head of R&D for Healthcare - prnewswire.com","headline":"Merck KGaA, Darmstadt, Germany, Announces Retirement of Luciano Rossetti, Global Head of R&D for Healthcare","sentiment":"neutral"}],"patents":[],"drugCount":8,"phaseCounts":{"phase_3":4,"phase_1":2,"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}